Naoki Hosogaya

593 citations

49 papers · 301 indexed · h-index 10

Infectious Diseases top 10%
- Antifungal resistance and susceptibility 13
Epidemiology
- Influenza Virus Research Studies 8
- Fungal Infections and Studies 8
- Respiratory viral infections research 6
- Pneumonia and Respiratory Infections 6
- Mycobacterium research and diagnosis 4
Small Animals top 10%
Modeling and Simulation
- COVID-19 epidemiological studies 4
Anesthesiology and Pain Medicine
Pulmonary and Respiratory Medicine
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4

Co-authors: Takahiro Takazono Hiroshi Mukae Katsunori Yanagihara Koichi Izumikawa Taiga Miyazaki Yoshifumi Imamura Masato Tashiro Shigeki Nakamura
Cited by: Infectious Diseases Epidemiology Small Animals
Journals: Clinical Infectious Diseases (3 papers)Scientific Reports (1 paper)The Journal of Infectious Diseases (1 paper)
Partner nations: Japan United States Poland

In The Last Decade

Naoki Hosogaya

42 papers receiving 299 citations

Peers

Countries citing papers authored by Naoki Hosogaya

Since Specialization

Citations

This map shows the geographic impact of Naoki Hosogaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Hosogaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Hosogaya more than expected).

Fields of papers citing papers by Naoki Hosogaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Hosogaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Hosogaya. The network helps show where Naoki Hosogaya may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Naoki Hosogaya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Naoki Hosogaya Line = papers co-authored together Naoki Hosogaya links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis from a Multicenter Observational Study in Kyushu and Okinawa, Japan Clinical Therapeutics ·Noriho Sakamoto,Masaki Okamoto,Kazunori Tobino,Hidenori Ichiyasu,Kazuya Ichikado,Hiroshi Ishii,Naoki Hamada,Kazuhiro Yatera,Taiga Miyazaki,Hiroshi Ishimoto,Takashi Kido,Takuto Miyramura,Shimpei Morimoto,Naoki Hosogaya,Hiroshi Mukae	2025	0
2	Prevotella intermedia Synergistically Exacerbates Pneumonia Induced by Oral Streptococci The Journal of Infectious Diseases ·Hiroki Ashizawa,Naoki Iwanaga,Kazuki Nemoto,Tatsuro Hirayama,Masataka Yoshida,Kazuaki Takeda,Shotaro Ide,Masato Tashiro,Naoki Hosogaya,Takahiro Takazono,Kosuke Kosai,Noriho Sakamoto,Koichi Izumikawa,Mariko Naito,Yoshimasa Tanaka,Katsunori Yanagihara,Kazuhiro Yatera,Hiroshi Mukae	2025	0
3	Risk Factors and Prognostic Effects of Aspergillosis as a Complication of Nontuberculous Mycobacterial Pulmonary Disease: A Nested Case–Control Study Mycoses ·Takahiro Takazono,Shotaro Ide,Motohiko Adomi,Y. Ogata,Yoshiyuki Saito,Masataka Yoshida,Kazuaki Takeda,Naoki Iwanaga,Naoki Hosogaya,Noriho Sakamoto,Izumi Sato,Akitsugu Furumoto,Koichi Izumikawa,Hiroshi Mukae	2025	2
4	A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still’s Disease (AOSD) Refractory to Corticosteroids Cureus ·Remi Sumiyoshi,Tomohiro Koga,Osamu Kamisawa,Shimpei Morimoto,Naoki Hosogaya,Hiroshi Yamamoto,Mariko Kawakami,Yosuke Inaba,Yoko Hattori,Tamiki Hikake,Tomoya Kurokawa,Hideki Hanaoka,Shuzo Sato,Kiyoshi Migita,Noriyoshi Ogawa,Motomu Hashimoto,Atsushi Kawakami	2025	0
5	Cost-Effectiveness Analysis of Influenza Treatments in Japan Using a Transmission Model: The Impact of Baloxavir and Oseltamivir Shares Infectious Diseases and Therapy ·Ataru Igarashi,Takahiro Takazono,Naoki Hosogaya,Naoya Itsumura,Shogo Miyazawa,Satoki Fujita,S. Eymere,Vladislav Berdunov,Mariia Dronova,Anna Tytuła,Hiroshi Mukae	2025	0
6	Neglected Pulmonary Infection Caused by Exophiala dermatitidis Misidentified as Rhodotorula spp. Mycoses ·Daichi Setoguchi,Naoki Iwanaga,Yuya Ito,Tatsuro Hirayama,Masataka Yoshida,Kazuaki Takeda,Shotaro Ide,Shinnosuke Takemoto,Masato Tashiro,Naoki Hosogaya,Takahiro Takazono,Kosuke Kosai,Hiroshi Ishimoto,Noriho Sakamoto,Yasushi Obase,Tomoya Nishino,Koichi Izumikawa,Katsunori Yanagihara,Hiroshi Mukae	2024	1
7	Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis Infectious Diseases and Therapy ·Takahiro Takazono,Yoshiyuki Saito,Masato Tashiro,Masataka Yoshida,Kazuaki Takeda,Shotaro Ide,Naoki Iwanaga,Naoki Hosogaya,Noriho Sakamoto,Hiroshi Mukae,Koichi Izumikawa	2024	1
8	Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells Antibiotics ·Naoki Iwanaga,Ayaka Ota,Hiroki Ashizawa,Yuya Ito,Tatsuro Hirayama,Masataka Yoshida,Kazuaki Takeda,Shotaro Ide,Masato Tashiro,Naoki Hosogaya,Noriho Sakamoto,Takahiro Takazono,Kosuke Kosai,Mariko Naito,Yoshimasa Tanaka,Kazuhiro Yatera,Koichi Izumikawa,Katsunori Yanagihara,Hiroshi Mukae	2024	1
9	Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza B Influenza and Other Respiratory Viruses ·Takahiro Takazono,G Ito,Naoki Hosogaya,Naoki Iwanaga,Takuji Komeda,Makiko Kobayashi,Yoshitake Kitanishi,Eriko Ogura,Hiroshi Mukae	2024	2
10	Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19 Infectious Diseases and Therapy ·Takahiro Takazono,Satoki Fujita,Takuji Komeda,Shogo Miyazawa,Yuki Yoshida,Yoshitake Kitanishi,Masahiro Kinoshita,Satoshi Kojima,Huilian Shen,Takeki Uehara,Naoki Hosogaya,Naoki Iwanaga,Hiroshi Mukae	2024	11
11	Pulmonary phaeohyphomycosis due to Exophiala dermatitidis in a patient with pulmonary non-tuberculous mycobacterial infection Journal of Infection and Chemotherapy ·Daichi Setoguchi,Naoki Iwanaga,Yuya Ito,Nobuyuki Ashizawa,Tatsuro Hirayama,Kazuaki Takeda,Shotaro Ide,Shinnosuke Takemoto,Masato Tashiro,Naoki Hosogaya,Takahiro Takazono,Noriho Sakamoto,Yasushi Obase,Koichi Izumikawa,Katsunori Yanagihara,Hiroshi Mukae	2023	4
12	The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database Mycoses ·Hotaka Namie,Takahiro Takazono,Yusuke Hidaka,Shimpei Morimoto,Yuya Ito,Nana Nakada,Nobuyuki Ashizawa,Tatsuro Hirayama,Kazuaki Takeda,Naoki Iwanaga,Masato Tashiro,Naoki Hosogaya,Takeshi Tanaka,Kiyohide Fushimi,Katsunori Yanagihara,Hiroshi Mukae,Koichi Izumikawa	2023	7
13	A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension Journal of Infection and Chemotherapy ·Daisuke Takao,Kazuaki Takeda,Takahiro Takazono,Mutsumi Ozasa,Yuya Ito,Nobuyuki Ashizawa,Tatsuro Hirayama,Naoki Iwanaga,Shinnosuke Takemoto,Shotaro Ide,Masato Tashiro,Naoki Hosogaya,Takashi Kido,Noriho Sakamoto,Yasushi Obase,Shinji Okano,Koichi Izumikawa,Katsunori Yanagihara,Hiroshi Mukae	2023	3
14	Serum Cytokine Changes in a Patient with Chronic Pulmonary Aspergillosis Overlapping with Allergic Bronchopulmonary Aspergillosis Internal Medicine ·Yusei Tsukamoto,Yuya Ito,Yasushi Obase,Takahiro Takazono,Nana Nakada,Nobuyuki Ashizawa,Tatsuro Hirayama,Kazuaki Takeda,Shotaro Ide,Naoki Iwanaga,Masato Tashiro,Naoki Hosogaya,Susumu Fukahori,Chizu Fukushima,Katsunori Yanagihara,Koichi Izumikawa,Hiroshi Mukae	2023	1
15	Impact of meteorological and demographic factors on the influenza epidemic in Japan: a large observational database study Scientific Reports ·G Ito,Takahiro Takazono,Naoki Hosogaya,Naoki Iwanaga,Shogo Miyazawa,Satoki Fujita,Hideaki Watanabe,Hiroshi Mukae	2023	2
16	Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study Mycoses ·Takahiro Takazono,Yusuke Hidaka,Shimpei Morimoto,Masato Tashiro,Nobuyuki Ashizawa,Tatsuro Hirayama,Kazuaki Takeda,Naoki Iwanaga,Naoki Hosogaya,Kazuko Yamamoto,Kiyohide Fushimi,Katsunori Yanagihara,Hiroshi Mukae,Koichi Izumikawa	2022	3
17	Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis Journal of Medical Economics ·Naoki Hosogaya,Takahiro Takazono,Akira Yokomasu,Shinzo Hiroi,Hidetoshi Ikeoka,Kosuke Iwasaki,Tomomi Takeshima,Hiroshi Mukae	2021	9
18	Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study) BMJ Open ·Kazuko Yamamoto,Naoki Hosogaya,Noriho Sakamoto,Haruo Yoshida,Hiroshi Ishii,Kazuhiro Yatera,Koichi Izumikawa,Katsunori Yanagihara,Hiroshi Mukae	2021	5
19	Efficacy and safety of nintedanib in Japanese patients with early-stage idiopathic pulmonary fibrosis: a study protocol for an observational study BMJ Open ·Noriho Sakamoto,Naoki Hamada,Masaki Okamoto,Kazunori Tobino,Hidenori Ichiyasu,Hiroshi Ishii,Kazuya Ichikado,Shimpei Morimoto,Naoki Hosogaya,Hiroshi Mukae	2021	2
20	An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance Medicine ·Tomohiro Koga,Naoko Hagimori,Shuntaro Sato,Shinpei Morimoto,Naoki Hosogaya,Chizu Fukushima,Hiroshi Yamamoto,Atsushi Kawakami	2020	9

About Naoki Hosogaya

Naoki Hosogaya is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology, having authored 49 papers that have together received 301 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (13 papers), Influenza Virus Research Studies (8 papers), Fungal Infections and Studies (8 papers), Respiratory viral infections research (6 papers), Pneumonia and Respiratory Infections (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Mycobacterium research and diagnosis (4 papers) and COVID-19 epidemiological studies (4 papers). The work is most often cited by research in Infectious Diseases (164 citations), Epidemiology (152 citations) and Small Animals (26 citations). Naoki Hosogaya has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Takahiro Takazono, Hiroshi Mukae, Katsunori Yanagihara, Koichi Izumikawa, Taiga Miyazaki, Yoshifumi Imamura, Masato Tashiro, Shigeki Nakamura, Hiroshi Kakeya and Shigeru Kohno. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact